In a real-world diverse population of patients with early triple-negative breast cancer (TNBC), 34% of patients who received ...

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses new treatments for HR+/HER2- breast cancer and immunotherapy challenges, ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Maternal hidradenitis suppurativa was linked to an increased risk for pregnancy complications and long-term adverse outcomes in mothers and children.

In a response to a survey, caregivers of people with spinal muscular atrophy identified the risk of severe adverse events and ...

In this cohort study of hospital admissions among Medicare patients during the COVID-19 pandemic, greater hospital COVID-19 burden was associated with an increased risk of in-hospital adverse effects ...

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...

Dr Graff discusses the differences and similarities in managing adverse events associated with bispecific antibodies in ...

Abdulraheem Yacoub, MD, discusses the adverse event profile of imetelstat when treating patients with myelodysplastic ...

Andrew Kim, B.S. was honored with a “Best Paper” at the recent North American Spine Society (NASS) meeting in Chicago. His ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

Revelation: Pfizer’s Dangerous Knowledge About COVID-19 Vaccine Risks** New evidence is surfacing that suggests Pfizer was well aware of serious adverse events linked to its C ...